Login
  • Therapeutic Area
    • Metabolic
  • Resources
  • Contact
Login

  • Add
  •  

    Resources

    VIDEOS

    Are your T2D patients on the right DPP4i dose?

    00:48

    Are your T2D patients on the right DPP4i dose?
    DPP4i - Proven efficacy with no dose reduction

    00:38

    DPP4i - Proven efficacy with no dose reduction
    DPP4i – What efficacy to expect?

    00:27

    DPP4i – What efficacy to expect?
    Efficacy, Safety, Simplicity all in one DPP4i

    00:54

    Efficacy, Safety, Simplicity all in one DPP4i
    JENTADUETO® dosing information

    01:22

    JENTADUETO® dosing information
    Renally impaired patients - Are they on the right dose?

    00:38

    Renally impaired patients - Are they on the right dose?
    Restricting TRAJENTA® to only renally impaired patients

    00:21

    Restricting TRAJENTA® to only renally impaired patients
    EMPA-REG Outcome Results - Video

    02:30

    EMPA-REG Outcome Results - Video
    High Residual CV Risk

    01:32

    High Residual CV Risk
    Value Proposition

    03:20

    Value Proposition
    Load more
    Close ×
    • Therapeutic Area
    • Metabolic
    • Resources
    • Videos
    • Clinical studies
    • Site map
    • Terms of use
    • Privacy
    • Contact
    • Change country

    © 2010-2026
    Boehringer Ingelheim International GmbH.
    All rights reserved.